technetium-tc-99m-medronate and Drug-Hypersensitivity

technetium-tc-99m-medronate has been researched along with Drug-Hypersensitivity* in 4 studies

Other Studies

4 other study(ies) available for technetium-tc-99m-medronate and Drug-Hypersensitivity

Article	Year
Bone scan 14 days after a toxic lignocaine reaction. Clinical nuclear medicine, 2004, Volume: 29, Issue:1 Topics: Adult; Anaphylaxis; Angioedema; Diagnosis, Differential; Drug Hypersensitivity; Female; Humans; Incidental Findings; Lidocaine; Pain; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate	2004
Delayed-type allergy to technetium Tc 99m. Contact dermatitis, 1998, Volume: 39, Issue:5 Topics: Bone Diseases; Diagnosis, Differential; Drug Hypersensitivity; Female; Humans; Hypersensitivity; Hypersensitivity, Delayed; Injections, Intravenous; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate	1998
Severe reaction to diphosphonate: implications for treatment of Paget's disease. BMJ (Clinical research ed.), 1988, Sep-03, Volume: 297, Issue:6648 Topics: Clobetasol; Drug Hypersensitivity; Erythema Multiforme; Female; Humans; Middle Aged; Osteitis Deformans; Technetium Tc 99m Medronate; Vasculitis	1988
Adverse allergic reaction to technetium-99m methylene diphosphonate. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1985, Volume: 26, Issue:4 Adverse allergic reactions to radiopharmaceuticals are rare but have been documented in the literature. This report presents data consistent with a definite adverse reaction to the radiopharmaceutical [99mTc]MDP. Topics: Bone Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Diphosphonates; Drug Hypersensitivity; Female; Humans; Lung Neoplasms; Middle Aged; Radionuclide Imaging; Technetium; Technetium Tc 99m Medronate; Time Factors	1985